Align Wealth Management LLC Makes New $323,000 Investment in JPMorgan Chase & Co. (NYSE:JPM)

Align Wealth Management LLC bought a new position in JPMorgan Chase & Co. (NYSE:JPM) in the fourth quarter, HoldingsChannel.com reports. The fund bought 3,090 shares of the financial services provider’s stock, valued at approximately $323,000. JPMorgan Chase & Co. accounts for 0.3% of Align Wealth Management LLC’s portfolio, making the stock its 22nd largest position.

A number of other large investors have also added to or reduced their stakes in the stock. Parkside Advisors LLC bought a new stake in shares of JPMorgan Chase & Co. during the 4th quarter valued at $248,000. Brookstone Capital Management grew its position in shares of JPMorgan Chase & Co. by 8.5% during the 4th quarter. Brookstone Capital Management now owns 165,878 shares of the financial services provider’s stock valued at $22,881,000 after acquiring an additional 12,997 shares during the period. Pure Financial Advisors LLC grew its position in shares of JPMorgan Chase & Co. by 49.9% during the 4th quarter. Pure Financial Advisors LLC now owns 3,613 shares of the financial services provider’s stock valued at $485,000 after acquiring an additional 1,203 shares during the period. CGN Advisors LLC grew its position in shares of JPMorgan Chase & Co. by 52.1% during the 4th quarter. CGN Advisors LLC now owns 14,918 shares of the financial services provider’s stock valued at $2,000,000 after acquiring an additional 5,110 shares during the period. Finally, MinichMacGregor Wealth Management LLC boosted its holdings in JPMorgan Chase & Co. by 33.8% in the 4th quarter. MinichMacGregor Wealth Management LLC now owns 4,666 shares of the financial services provider’s stock worth $626,000 after buying an additional 1,180 shares during the period. Institutional investors own 67.89% of the company’s stock.

JPMorgan Chase & Co. Stock Down 3.8 %

Shares of NYSE JPM opened at $125.81 on Friday. The firm’s 50-day moving average price is $139.06 and its 200-day moving average price is $129.21. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $370.30 billion, a price-to-earnings ratio of 10.41, a P/E/G ratio of 2.09 and a beta of 1.12. JPMorgan Chase & Co. has a 12-month low of $101.28 and a 12-month high of $144.34.

JPMorgan Chase & Co. (NYSE:JPM – Get Rating) last posted its quarterly earnings data on Friday, January 13th. The financial services provider reported $3.57 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.46. JPMorgan Chase & Co. had a net margin of 24.34% and a return on equity of 14.68%. The company had revenue of $34.55 billion for the quarter, compared to analyst estimates of $34.23 billion. During the same period in the prior year, the company posted $3.33 EPS. The firm’s revenue for the quarter was up 18.1% on a year-over-year basis. On average, equities research analysts anticipate that JPMorgan Chase & Co. will post 12.9 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently weighed in on JPM shares. Morgan Stanley upped their target price on shares of JPMorgan Chase & Co. from $167.00 to $173.00 and gave the stock an “overweight” rating in a report on Friday, February 24th. Wells Fargo & Company raised shares of JPMorgan Chase & Co. from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $148.00 to $155.00 in a report on Monday, March 13th. Oppenheimer boosted their price target on shares of JPMorgan Chase & Co. from $177.00 to $186.00 and gave the stock an “outperform” rating in a research note on Thursday, February 2nd. Deutsche Bank Aktiengesellschaft cut shares of JPMorgan Chase & Co. from a “buy” rating to a “hold” rating and decreased their price target for the stock from $155.00 to $145.00 in a research note on Friday, January 6th. Finally, Citigroup boosted their price target on shares of JPMorgan Chase & Co. from $150.00 to $165.00 in a research note on Tuesday, January 17th. Six equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $150.78.

Insider Buying and Selling

In related news, General Counsel Stacey Friedman sold 23,148 shares of the stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $140.31, for a total value of $3,247,895.88. Following the sale, the general counsel now directly owns 48,311 shares of the company’s stock, valued at approximately $6,778,516.41. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, General Counsel Stacey Friedman sold 23,148 shares of the stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $140.31, for a total value of $3,247,895.88. Following the sale, the general counsel now directly owns 48,311 shares of the company’s stock, valued at approximately $6,778,516.41. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Peter Scher sold 4,399 shares of the stock in a transaction dated Tuesday, January 17th. The stock was sold at an average price of $140.32, for a total transaction of $617,267.68. Following the completion of the sale, the insider now directly owns 36,369 shares in the company, valued at $5,103,298.08. The disclosure for this sale can be found here. Insiders have sold 37,887 shares of company stock valued at $5,315,762 in the last ninety days. 0.79% of the stock is owned by company insiders.

JPMorgan Chase & Co. Company Profile

(Get Rating)

JPMorgan Chase & Co is a financial holding company, which engages in providing financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.